OnKure Therapeutics (OKUR) Misses Q1 EPS by 111c

OnKure Therapeutics (NASDAQ: OKUR) reported Q1 EPS of ($1.11).

For earnings history and earnings-related data on OnKure Therapeutics (OKUR) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• H.C. Wainwright Reiterates Buy Rating on LSI Industries (LYTS)
• GitLab Inc (GTLB) Reiterated at Neutral by UBS on Stable Demand Outlook Into the Print